Concentration-Dependent Selection of Small Phenotypic Differences in TEM β-Lactamase-Mediated Antibiotic Resistance

ABSTRACT In this paper, the first robust experimental evidence of in vitro and in vivo concentration-dependent selection of low-level antibiotic-resistant genetic variants is described. The work is based on the study of an asymmetric competition assay with pairs of isogenicEscherichia coli strains, differing only (apart from a neutral chromosomal marker) in a single amino acid replacement in a plasmid-mediated TEM-1 beta-lactamase enzyme, which results in the new TEM-12 beta-lactamase. The mixture was challenged by different antibiotic concentrations, both in vitro and in the animal model, and the selective process of the variant population was carefully monitored. A mathematical model was constructed to test the hypothesis that measured growth and killing rates of the individual TEM variants at different antibiotic concentrations could be used to predict quantitatively the strength of selection for TEM-12 observed in competition experiments at these different concentrations.

[1]  Fernando Baquero,et al.  Selection of Naturally Occurring Extended-Spectrum TEM β-Lactamase Variants by Fluctuating β-Lactam Pressure , 2000, Antimicrobial Agents and Chemotherapy.

[2]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[3]  J. Domagala,et al.  Effect of Fluoroquinolone Concentration on Selection of Resistant Mutants of Mycobacterium bovis BCG andStaphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.

[4]  F. Baquero,et al.  Efficacy of Ampicillin plus Ceftriaxone in Treatment of Experimental Endocarditis Due to Enterococcus faecalis Strains Highly Resistant to Aminoglycosides , 1999, Antimicrobial Agents and Chemotherapy.

[5]  A S Perelson,et al.  Drug concentration heterogeneity facilitates the evolution of drug resistance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Petrosino,et al.  β-Lactamases: protein evolution in real time , 1998 .

[7]  F. Baquero,et al.  Antibiotic-selective environments. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  W. Craig,et al.  Pharmacokinetic/pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men Tions Were Associated with Only a Slight Reduction in Bacterial , 2022 .

[9]  J. Petrosino,et al.  beta-Lactamases: protein evolution in real time. , 1998, Trends in microbiology.

[10]  F. Baquero,et al.  Selective compartments for resistant microorganisms in antibiotic gradients. , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  A. Medeiros,et al.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Medeiros,et al.  Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics , 1997 .

[13]  F. M. Stewart,et al.  The population genetics of antibiotic resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Schrag,et al.  Reducing antibiotic resistance , 1996, Nature.

[15]  M Travisano,et al.  Long-term experimental evolution in Escherichia coli. IV. Targets of selection and the specificity of adaptation. , 1996, Genetics.

[16]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[17]  F. Baquero,et al.  Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases , 1995, Antimicrobial agents and chemotherapy.

[18]  M. Larocco,et al.  Effect of threonine-to-methionine substitution at position 265 on structure and function of TEM-1 beta-lactamase , 1994, Antimicrobial Agents and Chemotherapy.

[19]  F. Baquero,et al.  In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations , 1994, Antimicrobial Agents and Chemotherapy.

[20]  F. Baquero,et al.  Single Amino Acid Replacements at Positions Altered in Naturally Occurring Extended-Spectrum TEM b-Lactamases , 1994 .

[21]  F. Baquero,et al.  Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli , 1991 .

[22]  F. Baquero,et al.  Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. , 1991, The Journal of antimicrobial chemotherapy.

[23]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[24]  R. Lenski.  EXPERIMENTAL STUDIES OF PLEIOTROPY AND EPISTASIS IN ESCHERICHIA COLI. I. VARIATION IN COMPETITIVE FITNESS AMONG MUTANTS RESISTANT TO VIRUS T4 , 1988, Evolution; international journal of organic evolution.

[25]  H. Krisch,et al.  Interposon mutagenesis of soil and water bacteria: a family of DNA fragments designed for in vitro insertional mutagenesis of gram-negative bacteria. , 1987, Gene.

[26]  L. Darden.  The Nature of Selection: Evolutionary Theory in Philosophical Focus , 1986 .

[27]  A. Pugsley,et al.  Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. , 1986, Journal of general microbiology.

[28]  Elliott Sober,et al.  The Nature of Selection: Evolutionary Theory in Philosophical Focus , 1986 .

[29]  B. Spratt,et al.  Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. , 1986, Gene.

[30]  R. Lenski,et al.  Constraints on the Coevolution of Bacteria and Virulent Phage: A Model, Some Experiments, and Predictions for Natural Communities , 1985, The American Naturalist.

[31]  S. Mizushima,et al.  Regulation of outer membrane porin protein synthesis in Escherichia coli K-12: ompF regulates the expression of ompC , 1983, Journal of bacteriology.

[32]  Y. Chabbert,et al.  Role of porin proteins OmpF and OmpC in the permeation of beta-lactams , 1982, Antimicrobial Agents and Chemotherapy.

[33]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[34]  U. Henning,et al.  Major proteins of the Escherichia coli outer cell envelope membrane as bacteriophage receptors , 1977, Journal of bacteriology.

[35]  F. M. Stewart,et al.  Resource-Limited Growth, Competition, and Predation: A Model and Experimental Studies with Bacteria and Bacteriophage , 1977, The American Naturalist.

[36]  N. Datta,et al.  Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae , 1965, Nature.